General Atlantic to invest $100 million in Rubicon
Rubicon plans to use the money to bring to market innovative medicines and expand manufacturing across the world
General Atlantic had on 1 April acquired a majority stake in Rubicon by buying out existing investor Everstone Group
Mumbai: Private equity firm General Atlantic will invest $100 million in Rubicon Research Pvt. Ltd, the pharmaceutical product development company in which it acquired a controlling stake last week.